Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Fluid Balance Control in Critically Ill Patients
NCT02765009Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jun 2016
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Randomised, open-label trial in critical illness and Fluid overload (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: All-cause mortality at 60 days. Started Jun 2016; status: completed.
02
Conditions
critical illnessFluid overload
Beyond the preview
Go deeper on NCT02765009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765009.